Role of echocardiography in patients treated with immune checkpoints inhibitors

被引:0
作者
Kazuaki Tanabe
Junya Tanabe
机构
[1] Shimane University,Division of Cardiology, Faculty of Medicine
关键词
Cancer; Adverse events; Myocarditis; Electrocardiography; Strain;
D O I
暂无
中图分类号
学科分类号
摘要
Immune-related adverse events occurring in the heart (cardiac immune-related adverse events; irAEs) by immune checkpoint inhibitors (ICIs) include myocarditis, arrhythmia, conduction disturbance, pericardial diseases, and takotsubo cardiomyopathy. Cardiac irAEs are rare but life-threatening. In cardio-oncology, the study of cardiac disorders caused by cancer treatment has recently attracted attention, and such studies may elucidate the pathophysiology of cardiac irAEs and contribute to management strategies. This review discusses the pathogenic mechanisms underlying cardiac irAEs and the role of echocardiography in patients treated with ICIs.
引用
收藏
页码:145 / 148
页数:3
相关论文
共 64 条
[1]  
Onishi T(2021)Practical guidance for echocardiography for cancer therapeutics-related cardiac dysfunction J Echocardiogr 19 1-20
[2]  
Fukuda Y(2019)The impending epidemic of cardiovascular diseases in patients with cancer in Japan Circ J 83 2191-2202
[3]  
Miyazaki S(2019)Cardiovascular toxicities of immune checkpoint inhibitors J Am Coll Cardiol 74 1714-1727
[4]  
Okura Y(2020)Immune-related adverse events of checkpoint inhibitors Nat Rev Dis Primers 6 38-310
[5]  
Ozaki K(2000)Immunologic self-tolerance maintained by CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J Exp Med 192 303-98
[6]  
Tanaka H(2021)Mechanisms and management of immune checkpoint inhibitor-related cardiac adverse events JMA J 4 91-12
[7]  
Ball S(2018)Immune checkpoint inhibitor-related myocarditis Jpn J Clin Oncol 48 7-1589
[8]  
Ghosh RK(2018)Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study Lancet Oncol 19 1579-947
[9]  
Wongsaengsak S(2019)Takotsubo syndrome in patients with cancer treated with immune checkpoint inhibitors: a new adverse cardiac complication Eur J Heart Fail 21 945-1755
[10]  
Ramos-Casals M(2016)Fulminant myocarditis with combination immune checkpoint blockade N Engl J Med 375 1749-1764